Cancer registry professionals are facing a wave of new vendors claiming to offer "AI-powered" solutions for casefinding and abstraction.
At a recent Inspirata AI webinar, ODS leaders described a troubling pattern: platforms built by engineers with no oncology background, no NAACCR or SEER fluency, and no track record of results.
To help registries cut through the noise, this white paper distills those real-world experiences into a five-domain evaluation framework — the questions to ask, the answers that signal real capability, and the red flags that mean it's time to walk away.